Prairie Capital Acquires Specialty Blood Products Company Seraplex

Prairie Capital has acquired Seraplex, a California-based specialty blood products company. Financial terms of the acquisition were not disclosed.

WaveEdge Capital, an investment bank focused on the healthcare and life sciences sectors, acted as the exclusive sell-side M&A advisor to Seraplex. The company has a history of supplying specialty blood products to global diagnostic and therapeutic manufacturing firms for over fifty years.

Demand for Seraplex's specialized products is reportedly increasing due to advancements in precision medicine and therapeutic development. The company has expanded its offerings beyond standard specimens to include specialty and disease-state products, while maintaining a focus on quality and customer service.

Prairie Capital, headquartered in Chicago, focuses on investing in high-potential, founder-owned companies. The acquisition is expected to integrate Seraplex with a consortium of Prairie Capital's biospecimen companies, enhancing their combined product and service offerings for the biopharmaceutical and diagnostic industries.